Showing 5,761 - 5,780 results of 106,501 for search '(( 5 ((nn decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (mean decrease)) ))', query time: 1.46s Refine Results
  1. 5761
  2. 5762
  3. 5763
  4. 5764

    Pro-apoptotic markers are decreased after IGFBP-3 NB injections. by Youde Jiang (436930)

    Published 2014
    “…<p>For all studies, groups are control (ctrl), diabetic (Diabetic), Diabetic +IGFBP-3 NB (Diab +BP3), Diabetic +CMV (Diab+CMV), Diabetic+IGFBP-3 NB left eye (Diab+BP3 contra) and Diabetic+CMV left eye (Diab+CMV Contra). Panels A&B show that Bax (A) and cleaved caspase 3 (B) levels are all decreased after the IGFBP-3 NB intravitreal injections. …”
  5. 5765
  6. 5766
  7. 5767
  8. 5768
  9. 5769
  10. 5770
  11. 5771
  12. 5772
  13. 5773
  14. 5774

    Brivanib decreases viability of PDGF-BB treated LX-2 cells. by Ikuo Nakamura (548298)

    Published 2014
    “…(B) Cells stimulated with 5 ng/ml PDGF-BB in serum-free medium showed a similar trend albeit more pronounced decrease in viability compared to cells cultured in 10% FBS. …”
  15. 5775

    Decreased liver metastasis of circulating CXCL12-expressing PDAC cells. by Ishan Roy (530438)

    Published 2014
    “…(C) <i>Ex vivo</i> radiance of excised spleen (C), reflecting tumor cells at the site of injection, or the metastatic destination (D), reflecting decreased hepatic metastasis of CXCL12-expressing cells relative to GFP-cells. (**) denotes <i>P</i>≤0.01, n = 4–5. …”
  16. 5776
  17. 5777
  18. 5778

    Autocrine CXCL12 decreases cell adhesion of colorectal carcinoma cells. by Luke J. Drury (241337)

    Published 2010
    “…GAPDH expression served as a loading control. (B) HT29 cells cultured in complete medium exhibit decreased adhesion after 6-days in culture (D0, D2, D4, D5, D6) compared to control (GFP) cells by phase microscopy (10X). …”
  19. 5779
  20. 5780

    Antisense RNA decreases AP33 gene expression and cytoadherence by -1 by V Mundodi (32881)

    Published 2011
    “…The blots were probed with mAb F5.2 to AP33 (panel 1), mAb 12G4 to AP65 (panel 2) [17], and mAb to α-tubulin (panel 3). …”